• 西安醫(yī)科大學(xué)第一臨床醫(yī)學(xué)院普外科(西安710061);

為了解增殖細胞核抗原(PCNA)在胃腫瘤中的表達及其臨床意義,應(yīng)用免疫組化技術(shù)(ABC法),對胃腫瘤(胃腺瘤性息肉10例,胃癌94例)組織切片中PCNA含量進行半定量檢測。結(jié)果:①胃粘膜不同病理狀態(tài)下PCNA指數(shù)差異有極顯著性意義(P lt;0.01);②PCNA指數(shù)與患者的性別和年齡無關(guān)(P gt;0.05),而與腫瘤的生長方式、組織類型、漿膜層受侵與否、淋巴結(jié)轉(zhuǎn)移與否和臨床分期關(guān)系密切(P lt;0.05);③PCNA指數(shù)與胃癌的預(yù)后密切相關(guān)(P lt;0.05),弱級(Ⅰ~Ⅱ級)表達的患者預(yù)后好。由此表明,PCNA檢測可作為判斷胃癌生物學(xué)行為和預(yù)后的良好指標(biāo)之一。

引用本文: 王康,孫學(xué)軍,賈宗良,王宏軍. 胃腫瘤中增殖細胞核抗原表達的臨床研究. 中國普外基礎(chǔ)與臨床雜志, 1999, 6(4): 224-226. doi: 復(fù)制

版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. ShouW,GregoryJH,DavidB,etal.Thep21inhibitorofcyclyindependentkinasescontrolDNAreplicationbyinteractionwithPCNA.Nature,1994;369(16)∶574.
2. DierendonckJH,WijsmanJH,KeijzerR,etal.Cellcyclerelatedstainingpatternsofantiproliferatingcellnuclearantigenmonoclonalantibodies.ComparisonwithBrdUrdlabelingandKi67staning.AmJPathol,1991;138(5)∶1165.
3. NishidaT,TanakaS,HarurmaK,etal.Histologicgradeandcellularproliferationatthedeepestinvasiveportioncorrelatewiththehighmalignancyofsubmucosalinvasivegastriccarcinoma.Oncology,1995;52(4)∶346.
4. ShirokoT,SajiS,KawaguchiY,etal.AstudyontherelationshipbetweenclinicalpathologicalfindingsofgastriccanceranditsbiologicalbehaviorsuchasDNAploidypatternandimmunohistochemicalstainingofPCNA,laminin,p53andnm23.GanToKagakuRyoho,1995;22(Suppl2)∶118.
5. MoriM,KakejiY,AdachiY,etal.Theprognosticsignificanceofproliferatingcellnuclearantigeninclinicalgastriccancer.Surgery,1993;113(6)∶683.
  1. 1. ShouW,GregoryJH,DavidB,etal.Thep21inhibitorofcyclyindependentkinasescontrolDNAreplicationbyinteractionwithPCNA.Nature,1994;369(16)∶574.
  2. 2. DierendonckJH,WijsmanJH,KeijzerR,etal.Cellcyclerelatedstainingpatternsofantiproliferatingcellnuclearantigenmonoclonalantibodies.ComparisonwithBrdUrdlabelingandKi67staning.AmJPathol,1991;138(5)∶1165.
  3. 3. NishidaT,TanakaS,HarurmaK,etal.Histologicgradeandcellularproliferationatthedeepestinvasiveportioncorrelatewiththehighmalignancyofsubmucosalinvasivegastriccarcinoma.Oncology,1995;52(4)∶346.
  4. 4. ShirokoT,SajiS,KawaguchiY,etal.AstudyontherelationshipbetweenclinicalpathologicalfindingsofgastriccanceranditsbiologicalbehaviorsuchasDNAploidypatternandimmunohistochemicalstainingofPCNA,laminin,p53andnm23.GanToKagakuRyoho,1995;22(Suppl2)∶118.
  5. 5. MoriM,KakejiY,AdachiY,etal.Theprognosticsignificanceofproliferatingcellnuclearantigeninclinicalgastriccancer.Surgery,1993;113(6)∶683.